[1]王 娜,彭 琼,戴 夫.RFH-NPT在肝硬化患者营养评估中的应用[J].医学信息,2020,33(17):85-88.[doi:10.3969/j.issn.1006-1959.2020.17.024]
　WANG Na,PENG Qiong,DAI Fu.Application of RFH-NPT in Nutritional Assessment of Patients with Liver Cirrhosis[J].Medical Information,2020,33(17):85-88.[doi:10.3969/j.issn.1006-1959.2020.17.024]
点击复制

RFH-NPT在肝硬化患者营养评估中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年17期
页码:
85-88
栏目:
论著
出版日期:
2020-09-01

文章信息/Info

Title:
Application of RFH-NPT in Nutritional Assessment of Patients with Liver Cirrhosis
文章编号:
1006-1959（2020）17-0085-04
作者:
王 娜; 彭 琼;  戴 夫
（安徽医科大学第三附属医院/合肥市第一人民医院消化内科，安徽 合肥 230001）
Author(s):
WANG Na; PENG Qiong; DAI Fu
(The Third Affiliated Hospital of Anhui Medical University/Department of Gastroenterology,Hefei First People’s Hospital,Hefei 230001,Anhui,China)
关键词:
肝硬化; 营养不良; RFH-NPT; NRS-2002
Keywords:
Liver cirrhosis; Malnutrition; RFH-NPT; NRS-2002
分类号:
R575.2
DOI:
10.3969/j.issn.1006-1959.2020.17.024
文献标志码:
A
摘要:
目的 比较皇家自由医院-营养优先排序工具（RFH-NPT）与营养风险筛查2002（NRS-2002）在肝硬化患者营养评估中应用价值。方法 收集安徽医科大学第三附属医院2018年6月~2019年6月消化科及感染科住院肝硬化患者80例，入院后24 h内完成性别、年龄、吸烟饮酒史的登记，测量计算体质指数（BMI）、肱三头肌皮褶厚度（TSF）、上臂肌围（AC），收集实验室指标，包括白蛋白（ALB）、血红蛋白（Hb）、谷丙转氨酶（ALT）、谷草转氨酶（AST）、肌酐（BUN）、凝血酶原时间（PT）、国际标准化比值（INR），应用Child-Pugh 评分将所有患者分为 A、B、C3级，使用RFH-NPT及NRS-2002分别对患者进行营养风险评估，分别比较传统营养指标结果、RFH-NPT评估结果、NRS-2002评估结果三者之间的关系。结果 RFH-NPT和NRS-2002分别筛选出65.00%、56.26%的肝硬化患者存在营养不良；营养不良风险随着肝脏储备功能的下降而升高，RFH-NPT与NRS-2002相比医院风险筛出率更（?字2NRS-2002=6.532，PNRS-2002=0.038；?字2RFH-NPT=11.167，PRFH-NPT=0.040）；RFH-NPT评估时营养不良组ALB、肱三头肌皮褶厚度、AC、Hb水平均低于正常营养组，差异有统计学意义（P＜0.05），两组BMI比较，差异无统计学意义（P＞0.05）；NRS-2002评估时营养不良组ALB、TSF、AC水平均低于正常营养组，差异有统计学意义（P＜0.05），而两组之间Hb、BMI分别比较时，差异无统计学意义（P＞0.05）。结论 RFH-NPT在住院肝硬化患者营养评估筛查中价值高于NRS2002，是肝硬化患者营养评估的更为有效的工具，避免了SGA与NRS2002所存在的影响因素的作用，并且其操作简单、灵敏度高等特点有助于临床医师对肝硬化患者营养不良的早期发现，但仍需要大量样本进行反复验证。
Abstract:
Objective To compare the value of Royal Free Hospital-Nutrition Prioritization Tool (RFH-NPT) and Nutrition Risk Screening 2002 (NRS-2002) in nutritional assessment of patients with liver cirrhosis.Methods A total of 80 patients with liver cirrhosis in the Department of Gastroenterology and Infectious Diseases from June 2018 to June 2019 in the Third Affiliated Hospital of Anhui Medical University were collected. The registration of gender, age, smoking and drinking history was completed within 24 hours after admission, and the body mass index was measured and calculated (BMI), triceps skinfold thickness (TSF), upper arm muscle circumference (AC), collect laboratory indicators, including albumin (ALB), hemoglobin (Hb), alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine (BUN), prothrombin time (PT), international normalized ratio (INR), all patients were divided into A, B, C3 grades using Child-Pugh score, and RFH-NPT and NRS-2002 were used to treat patients respectively carry out nutritional risk assessment and compare the relationship between the results of traditional nutritional indicators, the results of RFH-NPT, and the results of NRS-2002.Results RFH-NPT and NRS-2002 respectively screened 65.00% and 56.26% of patients with liver cirrhosis to have malnutrition; the risk of malnutrition increases with the decline of liver reserve function. Compared with NRS-2002, RFH-NPT screens out the hospital risk rate was even higher (?字2NRS-2002=6.532, PNRS-2002=0.038;?字2RFH-NPT=11.167, PRFH-NPT=0.040); the malnutrition group ALB, TSF, AC, Hb level in the RFH-NPT assessment was lower than the normal nutrition group,the difference was statistically significant (P＜0.05). There was no statistically significant difference in BMI between the two groups (P＞0.05); the levels of ALB, TSF, and AC in the malnutrition group were lower than those in the normal nutrition group when assessed by NRS-2002. There was statistical significance (P＜0.05), but when Hb and BMI were compared between the two groups, the difference was not statistically significant (P＞0.05).Conclusion RFH-NPT was more valuable than NRS2002 in the nutritional assessment and screening of inpatients with liver cirrhosis. It was a more effective tool for nutritional assessment of patients with liver cirrhosis. It avoided the effects of the influencing factors of SGA and NRS2002, and its operation was simple,the high sensitivity and other features were helpful for clinicians in the early detection of malnutrition in patients with liver cirrhosis, but a large number of samples were still needed for repeated verification.

参考文献/References:

[1]European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel: Chair:; Panel members; EASL Governing Board representative:. EASL Clinical Practice Guidelines: Drug-induced liver injury[J].J Hepatol,2019,70(6):1222-1261.[2]Amodio P,Bemeur C,Butterworth R,et al.The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus[J].Hepatology,2013,58(1):325-336.[3]Kondrup J,Allison SP,Elia M,et al.ESPEN guidelines for nutrition screening 2002[J].Clinical Nutrition,2003,22(4):415-421.[4]Arora S,Mattina C,Mcanenny C,et al.OC-075Assessment of nutritional status in patients with cirrhosis:must is not a must[J].Gut,2012,61(Suppl 2):A32.[5]Bajaj JS,Reddy KR,Tandon P,et al.The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis[J].Hepatology,2016,64(1):200-208.[6]Scaglione SJ,Metcalfe L,Kliethermes S,et al.Early Hospital Readmissions and Mortality in Patients With Decompensated Cirrhosis Enrolled in a Large National Health Insurance Administrative Database[J].J Clin Gastroenterol,2017,51(9):839-844.[7]Burra P,Giannini EG,Caraceni P,et al.Specific issues concerning the management of patients on the waiting list and after liver transplantation[J].Liver Int,2018,38(8):1338-1362.[8]Palmer LB,Kuftinec G,Pearlman M,et al.Nutrition in Cirrhosis[J].Current Gastroenterology Reports,2019,21(8):38.[9]Lee JL,Oh ES,Lee RW,et al.Serum Albumin and Prealbumin in Calorically Restricted,Nondiseased Individuals:A Systematic Review[J].American Journal of Medicine,2015,128(9):1023.e1-1023.e22.[10]Periyalwar P,Dasarathy S.Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses[J].Clin Liver Dis,2012,16(1):95-131.[11]Detsky AS,McLaughlin JR,Baker JP,et al.What is subjective global assessment of nutritional status?1987.Classical article[J].Nutricion Hospitalaria,2008,23(4):400.[12]Spatola L,Finazzi S,Santostasi S,et al.Geriatric Nutritional Risk Index Is Predictive of Subjective Global Assessment and Dialysis Malnutrition Scores in Elderly Patients on Hemodialysis[J].Journal of Renal Nutrition,2019,29(5):438-443.[13]Barata AT,Santos C,Cravo M,et al.Handgrip Dynamometry and Patient-Generated Subjective Global Assessment in Patients with Nonresectable Lung Cancer[J].Clinical Nutrition,2015(34):S255.[14]Badia-Tahull MB,Cobo-Sacristán S,Leiva-Badosa E,et al.Use of Subjective Global Assessment, Patient-Generated Subjective Global Assessment and Nutritional Risk Screening 2002 to evaluate the nutritional status of non-critically ill patients on parenteral nutrition[J].Nutr Hosp,2014,29(2):411-419.[15]吉琳琳,侯栋梁,宋丽楠,等.营养风险筛查2002、营养不良通用筛查工具和患者主观整体评估在住院肿瘤患者中应用和比较[J].营养学报,2017(3):242-246.[16]Parkash O,Iqbal R,Jafri F,et al.Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan[J].BMC Res Notes,2012(5):446.[17]Borhofen SM,Gerner C,Lehmann J,et al.The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis[J].Digestive Diseases&ences,2016,61(6):1735-1743.[18]Sherpa TW,Pathak R,Khadga PK,et al.Nutritional Assessment of Patients with Liver Cirrhosis by Nutrition Screening Tool and Anthropometry at a Tertiary Care Center[J].Journal of Institute of Medicine Nepal,2019,41(2):21.[19]李培敏,霍丽娟.肝硬化患者营养筛查与评估研究进展[J].肝脏,2020,25(1):91-93.[20]杨瑗,吴宇超,齐晓丽,等.RFH-NPT与NRS-2002在肝硬化住院患者营养风险评估中的应用比较[J].陕西医学杂志,2016,45(12):1661-1662.

相似文献/References:

[1]崔 洁.凝血酶原时间与血小板检验方式对诊断肝硬化疾病的临床价值研究[J].医学信息,2018,31(04):150.[doi:10.3969/j.issn.1006-1959.2018.04.055]
　CUI Jie.Study on the Clinical Value of Prothrombin Time and Platelet Examination in the Diagnosis of Liver Cirrhosis[J].Medical Information,2018,31(17):150.[doi:10.3969/j.issn.1006-1959.2018.04.055]
[2]祁兴顺,周新苗,许向波,等.肝硬化患者应用特利加压素治疗期间发生 低钠血症的现状研究[J].医学信息,2018,31(09):1.[doi:10.3969/j.issn.1006-1959.2018.09.001]
[3]桂志兵,汪文生.红细胞分布宽度与血小板计数比值在乙型肝炎肝硬化患者病情评估中的作用[J].医学信息,2018,31(20):65.[doi:10.3969/j.issn.1006-1959.2018.20.019]
　GUI Zhi-bing,WANG Wen-sheng.The Role of Red Blood Cell Distribution Width and Platelet Ratio in the Evaluation of Patients with Hepatitis B Cirrhosis[J].Medical Information,2018,31(17):65.[doi:10.3969/j.issn.1006-1959.2018.20.019]
[4]王晓刚.利拉鲁肽联合胰岛素泵对2 型糖尿病合并肝硬化患者血糖代谢及肝纤维化的影响[J].医学信息,2018,31(20):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
　WANG Xiao-gang.Effects of Liraglutide Combined with Insulin Pump on Blood Glucose Metabolism and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Complicated with Cirrhosis[J].Medical Information,2018,31(17):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
[5]刘庆宪,罗 虹,冯妙莲,等.补中健脾法对老年营养不良患者身体质量指数和相关蛋白质物质治疗价值的临床研究[J].医学信息,2018,31(21):152.[doi:10.3969/j.issn.1006-1959.2018.21.044]
　LIU Qing-xian,LUO Hong,FENG Miao-lian,et al.Clinical Study on the Therapeutic Value of Body Mass Iindex and Related Protein in Elderly Patients with Malnutrition by Invigorating the Spleen Method[J].Medical Information,2018,31(17):152.[doi:10.3969/j.issn.1006-1959.2018.21.044]
[6]赵华莹,李运泽,韦天灵,等.肝硬化合并门静脉血栓形成的危险因素分析[J].医学信息,2019,32(03):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
　ZHAO Hua-ying,LI Yun-ze,WEI Tian-ling,et al.Analysis of Risk Factors for Cirrhotic Patients with Portal Vein Thrombosis[J].Medical Information,2019,32(17):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
[7]张宏程.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的疗效观察[J].医学信息,2019,32(03):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
　ZHANG Hong-cheng.Therapeutic Effect of Somatostatin Combined with Pantoprazole on Hepatic Cirrhosis Complicated with Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(17):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
[8]张许林,余泽波.肝硬化上消化道出血的输血治疗进展[J].医学信息,2019,32(08):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
　ZHANG Xu-lin,YU Ze-bo.Progress in Transfusion Therapy for Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(17):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
[9]陈 杰.左旋肉碱治疗肝硬化并显性肝性脑病的效果观察[J].医学信息,2019,32(14):153.[doi:10.3969/j.issn.1006-1959.2019.14.051]
　CHEN Jie.Effect of L-carnitine on Liver Cirrhosis and Dominant Hepatic Encephalopathy[J].Medical Information,2019,32(17):153.[doi:10.3969/j.issn.1006-1959.2019.14.051]
[10]曹 宇,何其顺,郭雅雯,等.延时扫描对肝硬化患者肝脏增强CT检查中动脉期时相的影响[J].医学信息,2020,33(01):161.[doi:10.3969/j.issn.1006-1959.2020.01.053]
　CAO Yu,HE Qi-shun,GUO Ya-wen,et al.Effect of Delayed Scanning on the Phase of the Middle Arterial Phase of Liver Enhanced CT in Patients with Cirrhosis[J].Medical Information,2020,33(17):161.[doi:10.3969/j.issn.1006-1959.2020.01.053]

更新日期/Last Update: 1900-01-01